A retrospective study evaluating benefits of switching to raltegravir-containing regimens in the HIV+ older population.
Latest Information Update: 30 Dec 2016
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- Acronyms RAL-AGE
- 30 Dec 2016 New trial record